Search Results - "NISHIDA, KENRO"

Novel Imaging of Hypoglycemia-induced Myocardial Abnormality by Cardiac Magnetic Resonance T1-mapping by Nakade, Taisuke, Sumida, Hitoshi, Katahira, Kazuhiro, Nishida, Kenro

Get full text

Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes: a pilot, randomized, controlled study by Shimoda, Seiya, Sakamoto, Wakana, Hokamura, Ayaka, Matsuo, Yasuto, Sekigami, Taiji, Ichimori, Shinji, Iwashita, Shinsuke, Ishii, Norio, Otsu, Kae, Yoshimura, Ryohei, Nishiyama, Toshihiko, Sakaguchi, Masaji, Nishida, Kenro, Araki, Eiichi

“…To examine the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) or once-daily second-generation basal insulin analogs (insulin…”
Get full text

What is artificial endocrine pancreas? Mechanism and history by Nishida, Kenro, Shimoda, Seiya, Ichinose, Kenshi, Araki, Eiichi, Shichiri, Motoaki

“…The artificial endocrine pancreas is a feedback control instrument that regulates insulin delivery on a minute-by-minute basis according to measured blood…”
Get full text

Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy by Shimoda, Seiya, Iwashita, Shinsuke, Ichimori, Shinji, Matsuo, Yasuto, Goto, Rieko, Maeda, Takako, Matsuo, Tomoko, Sekigami, Taiji, Kawashima, Junji, Kondo, Tatsuya, Matsumura, Takeshi, Motoshima, Hiroyuki, Furukawa, Noboru, Nishida, Kenro, Araki, Eiichi

“…To assess the efficacy and safety of adding sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, in subjects with type 2 diabetes inadequately controlled…”
Get full text

Insulin requirement profiles in Japanese hospitalized subjects with type 2 diabetes treated with basal-bolus insulin therapy by Shimoda, Seiya, Okubo, Mina, Koga, Kotaro, Sekigami, Taiji, Kawashima, Junji, Kukidome, Daisuke, Igata, Motoyuki, Ishii, Norio, Shimakawa, Akiko, Matsumura, Takeshi, Motoshima, Hiroyuki, Furukawa, Noboru, Nishida, Kenro, Araki, Eiichi

“…To assess the total daily inulin dose (TDD) and contribution of basal insulin to TDD and to identify the predictive factors for insulin requirement profiles in…”
Get full text

Effects of Olmesartan, an Angiotensin II Receptor Blocker, on Peripheral Insulin Sensitivity in Japanese Subjects with Type 2 Diabetes and Hypertension by Shimoda, Seiya, Goto, Rieko, Furukawa, Noboru, Tsuruzoe, Kaku, Kawashima, Junji, Iwashita, Shinsuke, Maeda, Takako, Ichimori, Shinji, Ichinose, Kenshi, Nishida, Kenro, Araki, Eiichi

“…Objective Several studies have assessed the efficacy of angiotensin receptor blockers (ARBs) on peripheral insulin sensitivity using the euglycemic…”
Get full text

Possible relevance of alpha lipoic acid contained in a health supplement in a case of insulin autoimmune syndrome by Furukawa, Noboru, Miyamura, Nobuhiro, Nishida, Kenro, Motoshima, Hiroyuki, Taketa, Kayo, Araki, Eiichi

“…Abstract The insulin autoimmune syndrome is characterized as producing polyclonal or monoclonal anti-insulin autoantibodies in a patient with no previous…”
Get full text

Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naive Japanese adults with type 2 diabetes : a pilot, randomized, controlled study by Seiya Shimoda, Wakana Sakamoto, Ayaka Hokamura, Yasuto Matsuo, Taiji Sekigami, Shinji Ichimori, Shinsuke Iwashita, Norio Ishii, Kae Otsu, Ryohei Yoshimura, Toshihiko Nishiyama, Masaji Sakaguchi, Kenro Nishida, Eiichi Araki

“…Abstract. To examine the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) or once-daily second-generation basal insulin analogs…”
Get full text

A Case of ACTH-Independent Macronodular Adrenal Hyperplasia: Simultaneous Expression of Several Aberrant Hormone Receptors in the Adrenal Gland by MIYAMURA, NOBUHIRO, TSUTSUMI, ATSUYUKI, SENOKUCHI, HIROKO, NAKAMARU, KAZUHIKO, KAWASHIMA, JUNJI, SAKAI, KOHJI, TAGUCHI, TETSUYA, TOKUNAGA, HIROSHI, NISHIDA, KENRO, UEHARA, MASAYA, SAKAKIDA, MICHIHARU, ARAKI, EIICHI

“…ACTH-independent macronodular adrenal hyperplasia (AIMAH) is a rare cause of Cushing’s syndrome. Recently, aberrant expression of adrenal receptors for various…”
Get full text

Insulin requirement profiles in Japanese hospitalized subjects with type 2 diabetes treated with basal-bolus insulin therapy by Seiya Shimoda, Mina Okubo, Kotaro Koga, Taiji Sekigami, Junji Kawashima, Daisuke Kukidome, Motoyuki Igata, Norio Ishii, Akiko Shimakawa, Takeshi Matsumura, Hiroyuki Motoshima, Noboru Furukawa, Kenro Nishida, Eiichi Araki

“…Abstract. To assess the total daily inulin dose (TDD) and contribution of basal insulin to TDD and to identify the predictive factors for insulin requirement…”
Get full text

Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy by Seiya Shimoda, Shinsuke Iwashita, Shinji Ichimori, Yasuto Matsuo, Rieko Goto, Takako Maeda, Tomoko Matsuo, Taiji Sekigami, Junji Kawashima, Tatsuya Kondo, Takeshi Matsumura, Hiroyuki Motoshima, Noboru Furukawa, Kenro Nishida, Eiichi Araki

“…[Abstract.] To assess the efficacy and safety of adding sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, in subjects with type 2 diabetes inadequately…”
Get full text

Development of a highly responsive needle-type glucose sensor using polyimide for a wearable artificial endocrine pancreas by Ichimori, Shinji, Nishida, Kenro, Shimoda, Seiya, Sekigami, Taiji, Matsuo, Yasuto, Ichinose, Kenshi, Shichiri, Motoaki, Sakakida, Michiharu, Araki, Eiichi

“…To produce a long-life, stable, miniature glucose sensor for a wearable artificial endocrine pancreas (WAEP), we developed a novel microneedle-type glucose…”
Get full text

Enhanced, Simplified Glucose Sensors: Long-Term Clinical Application of Wearable Artificial Endocrine Pancreas by Shichiri, Motoaki, Sakakida, Michiharu, Nishida, Kenro, Shimoda, Seiya

“…At present, 2 major problems should be solved before long‐term application of the wearable artificial endocrine pancreas, the development of a reliable and…”
Get full text

Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas by Sekigami, Taiji, Shimoda, Seiya, Nishida, Kenro, Matsuo, Yasuto, Ichimori, Shinji, Ichinose, Kenshi, Shichiri, Motoaki, Sakakida, Michiharu, Araki, Eiichi

“…To establish the ideal insulin delivery route for an artificial endocrine pancreas, we examined the effectiveness of closed-loop portal insulin delivery. We…”
Get full text

871-P: Study of Glucagon Response and Its Association with Glycemic Control and Ketogenesis after Administration of Ipragliflozin as an Adjunctive Treatment in Patients with Type 1 Diabetes (Suglat-AID)—A Multicenter, Open-Label, Prospective Exploratory Trial by NAKAMURA, YUTA, HORIE, ICHIRO, ABIRU, NORIO, KITAMURA, TADAHIRO, KUSUNOKI, YOSHIKI, NISHIDA, KENRO, YAMAMOTO, AKANE, HIROTA, YUSHI, FUKUI, TOMOYASU, MAEDA, YASUTAKA, MINAMI, MASAE, MATSUI, TAKANORI, KAWAKAMI, ATSUSHI

“…Objective: SGLT2 inhibitors including ipragliflozin have been used as adjunctive to insulin therapy for the treatment of type 1 diabetes (T1D) in Japan…”
Get full text

Glucagon secretion and its association with glycaemic control and ketogenesis during sodium‐glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open‐label, prospective study by Nakamura, Yuta, Horie, Ichiro, Kitamura, Tadahiro, Kusunoki, Yoshiki, Nishida, Kenro, Yamamoto, Akane, Hirota, Yushi, Fukui, Tomoyasu, Maeda, Yasutaka, Minami, Masae, Matsui, Takanori, Kawakami, Atsushi, Abiru, Norio

“…Aim Clinical trials showed the efficacy of sodium‐glucose cotransporter 2 inhibitors for type 1 diabetes (T1D) by significant reductions in body weight and…”
Get full text

The benefits and accuracy of real-time continuous glucose monitoring in children and adolescents with type 1 diabetes attending a summer camp by Kondo, Tatsuya, Senokuchi, Takafumi, Morinaga, Jun, Miyashita, Azusa, Yano, Mayumi, Takeda, Haruo, Nishida, Kenro, Kubota, Naoto

“…This study evaluated the usability, satisfaction, and accuracy of a real-time continuous glucose monitoring (rt-CGM) in children and adolescents with type 1…”
Get full text

Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas by Matsuo, Yasuto, Shimoda, Seiya, Sakakida, Michiharu, Nishida, Kenro, Sekigami, Taiji, Ichimori, Shinji, Ichinose, Kenshi, Shichiri, Motoaki, Araki, Eiichi

“…The ultimate goal of the development of an artificial endocrine pancreas is to achieve long-term strict glycemic regulation. To establish the physiological…”
Get full text

Biocompatibility of MPC: in vivo evaluation for clinical application by Nowak, Tanja, Nishida, Kenro, Shimoda, Seiya, Konno, Yumi, Ichinose, Kenshi, Sakakida, Michiharu, Shichiri, Motoaki, Nakabayashi, Nobuo, Ishihara, Kazuhiko

“…Biocompatibility is important to assure a mild body reaction to an implanted device and its long-term stability and functionality. In diabetes research,…”
Get full text

Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes: a pilot, randomized, controlled study by Shimoda, Seiya, Sakamoto, Wakana, Hokamura, Ayaka, Matsuo, Yasuto, Sekigami, Taiji, Ichimori, Shinji, Iwashita, Shinsuke, Ishii, Norio, Otsu, Kae, Yoshimura, Ryohei, Nishiyama, Toshihiko, Sakaguchi, Masaji, Nishida, Kenro, Araki, Eiichi

“…To examine the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) or once-daily second-generation basal insulin analogs (insulin…”
Get full text